Google
CSBR — CHAMPIONS ONCOLOGY INC (Healthcare >> Biotechnology)
CSBR FAQ
What is CSBR's P/E ratio?
CHAMPIONS ONCOLOGY INC (CSBR) currently trades at a P/E ratio of 267.52.
What is CSBR's ROE?
CHAMPIONS ONCOLOGY INC reports a Return on Equity (ROE) of -53.26%.
What is CSBR's dividend yield?
CHAMPIONS ONCOLOGY INC offers a dividend yield of 0.00%.
What is CSBR's Deepscope Quality Score?
Deepscope rates CSBR's overall financial quality at 23 out of 100, based on profitability, growth, debt and earnings stability.
Is now a good time to buy CSBR?
Deepscope's AI Timing Score for CSBR is 0 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.
Which sector does CSBR belong to?
CHAMPIONS ONCOLOGY INC is classified under the Healthcare >> Biotechnology sector on the NASDAQ exchange.
|
USD 5.65
Price
-0.11
(-1.91%)
Day Change
|
|
|---|
CSBR, the overall quality is not good ( Quality = 23) and the timing to buy is ...(Sign In to See)...
Loading chart...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
P/E ratio is relatively high
ROE is relatively low.
ROA is relatively low.
Acceleration of ROE growth rate is below our criteria.
Negative growth of ROE in the last year.
ROE is decreasing significantly
Acceleration of ROA growth rate is below our criteria.
Current growth of ROA was below our criteria.
Net profit margin is relatively low.
Acceleration of net profit margin growth rate is below our criteria
Historical net profit margin is relatively low.
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Lorem ipsum dolor sit amet
In details, quality factors are not good , financial health is not good , and ability to make profit is not quite good , ...
| Quality Factors |
|
47% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 99 |
| Magic Formula Rank by ROA |
1809
|
| Magic Formula Rank by ROE |
1809
|
| Magic Formula Rank by ROIC |
1811
|
| Price | 5.65 |
| PBV / Sector |
18.27 / 4.63
|
| Earning Per Share | -0.16 |
| PE / Sector |
267.52 / 17.43
|
| PEG or PE/Growth / Sector |
-0.65 / 0.53
|
| Average 1M Daily Value |
0.06 M
GREAT
|
| Average 1W Daily Value |
0.03 M
GREAT
|
| Timing Factors |
|
14% |
| Financial Health |
|
45% |
| Ability to Make Profit |
|
52% |
| Return to Investors |
|
4% |
| Registration Details |
| Analyze Date | 2026-06-06 09:08:21 |
| Symbol | CSBR |
| Name | CHAMPIONS ONCOLOGY INC |
| Sector | Healthcare >> Biotechnology |
| Market | NASDAQ |
| Listed Shares | 13.89 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 79.99 / 8,857.28 |
| News, Concensus, ... |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: One University Plaza, Hackensack, NJ, United States, 07601
Phone: 201 808 8400
Website: https://www.championsoncology.com
Employees: 213
Sector: Healthcare >> Biotechnology
Description: Champions Oncology, Inc., a technology-enabled research company, provides technology solutions for drug discovery and development in the United States. The company, through its Tumorgraft technology platform, provides personalized cancer care based upon the implantation of human tumors in immune-deficient mice. It also offers translational oncology solutions that utilizes its technology platform to provide research services that assist in the drug development process of pharmaceutical and biotechnology companies. In addition, the company offers Lumin Bioinformatics, an oncology data-driven software program which contains comprehensive information derived from research services and clinical studies. It markets its products through internet and sales force to pharmaceutical and biotechnology companies. The company was formerly known as Champions Biotechnology, Inc. and changed its name to Champions Oncology, Inc. in April 2011. Champions Oncology, Inc. was incorporated in 1985 and is headquartered in Hackensack, New Jersey.
ME vs SECTOR Healthcare >> Biotechnology
Click a bubble to view stock details · Bubble size represents market capitalization share
